Pharmacological treatments in ARDS; a state-of-the-art update.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23957905.
- Also identified by DOI 10.1186/1741-7015-11-166 and PMC identifier PMC2636692.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.